RESIST-2: 2nd-line ART for HIV-2 Infection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
Prospective, longitudinal, open label, HIV-2 viral load and antiretroviral resistance informed 2nd-line ARV implementation study.
Epistemonikos ID: fcda862603e4993194adbc5bc53b70f010ff21f2
First added on: Mar 23, 2020